Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
kesimpta
novartis ireland ltd - ofatumumab - heila-og mænusigg, köstum tilkynnt - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
vortil innrennslisstofn, lausn 200 mg
williams & halls ehf - voriconazolum inn - innrennslisstofn, lausn - 200 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
efexor depot hart forðahylki 150 mg
upjohn eesv - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
efexor depot hart forðahylki 75 mg
upjohn eesv - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxin krka hart forðahylki 150 mg
krka sverige ab - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxin krka hart forðahylki 37,5 mg
krka sverige ab - venlafaxinum hýdróklóríð - hart forðahylki - 37,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxin krka hart forðahylki 75 mg
krka sverige ab - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxine bluefish hart forðahylki 150 mg
bluefish pharmaceuticals ab - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxine bluefish hart forðahylki 37,5 mg
bluefish pharmaceuticals ab - venlafaxinum hýdróklóríð - hart forðahylki - 37,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxine bluefish hart forðahylki 75 mg
bluefish pharmaceuticals ab - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg